Agostino Milluzzo
Current position:
- Fixed-term Researcher (Type B) in the Scientific Disciplinary Sector MEDS-08/C – Human Nutrition and Applied Dietetic Sciences, holding the National Scientific Qualification (ASN) for Associate Professorship, with clinical duties at the Diabetes and Obesity Center (U.O.S.D.) (Director: Prof. Lucia Frittitta), ARNAS “Garibaldi”, “Garibaldi-Nesima” Hospital, Catania, Italy
- Medical Doctor, Specialist in Endocrinology and Metabolic Diseases
Previous positions:
- Fixed-term Researcher (Type A), University of Catania
- PhD Candidate in Translational Biomedicine (International PhD Program, University of Catania, XXXV cycle)
- Research Fellow (pursuant to Article 22, paragraph 4, letter a, Law 240/2010), University of Catania
- Research Fellow, Italian Society of Diabetology (SID)
- NUTRITION AND NUTRACEUTICALS IN OBESITY AND DIABETES MELLITUS: Role of diet, vitamins, nutraceuticals, and adiposity in the development of chronic micro- and macrovascular complications, with particular focus on the pathogenesis of retinopathy in patients with type 2 diabetes mellitus and the influence of epigenetics and nutrient intake.
- DIABETES AND CANCER: Nutritional and pharmacological management of patients with diabetes and cancer; chronic micro- and macrovascular complications; biological mechanisms of carcinogenesis in diabetic and obese patients; metabolic and vascular complications in individuals cured of childhood-onset cancer and prevention strategies through healthy nutrition and adapted physical activity.
- OBESITY AND TYPE 2 DIABETES MELLITUS: Nutritional and pharmacological therapy with innovative agents; chronic micro- and macrovascular complications.
- DIABETES AND OBESITY IN PREGNANCY (pre-existing and gestational): Role of nutraceuticals in the management of diabetes during pregnancy (particularly gestational diabetes); nutritional therapy and carbohydrate counting; placental pathophysiology; diagnostic criteria and genetic and autoimmune variants of gestational diabetes; technology applied to glucose monitoring and insulin therapy; maternal and fetal/neonatal complications; predictive factors for diabetes after pregnancies complicated by gestational diabetes.
- TYPE 1 DIABETES MELLITUS: Nutritional therapy and carbohydrate counting; etiopathogenesis (role of epigenetics in the development of diabetes and related extra-pancreatic autoimmunity); technology applied to glucose monitoring and insulin therapy; chronic micro- and macrovascular complications; predictive factors of related extra-pancreatic autoimmunity.